Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
PFE	PFIZER INC	$161.04B	8.70%	3.70%	4.38%	6.80%	1.40	1.16	74.30%	12.40%	11.99%
MYGN	MYRIAD GENETICS INC	$444.16M	-79.80%	-46.90%	-67.14%	-97.80%	0.92	2.49	69.90%	-44.40%	-46.65%
UTMD	UTAH MEDICAL PRODUCTS INC	$201.04M	9.60%	9.30%	11.76%	72.00%	0.03	37.62	57.10%	29.30%	36.63%
ANGO	ANGIODYNAMICS INC	$426.00M	-17.60%	-11.70%	-16.52%	-36.80%	0.50	2.35	54.30%	-10.00%	-10.25%
WAT	WATERS CORP	$29.85B	28.50%	13.40%	21.49%	28.80%	0.98	1.73	59.30%	20.30%	26.05%
BSX	BOSTON SCIENTIFIC CORP	$93.22B	12.60%	6.90%	9.78%	16.90%	0.79	1.62	69.00%	14.40%	18.63%
XRAY	DENTSPLY SIRONA INC	$2.32B	-35.20%	-10.30%	-9.74%	-10.00%	3.05	1.51	50.00%	-16.30%	-10.82%
MGTX	MEIRAGTX HOLDINGS PLC	$747.68M	N/A	-53.30%	-83.70%	-65.60%	-43.19	0.75	94.00%	-140.30%	-125.33%
CDNA	CAREDX INC	$937.77M	-6.50%	-4.80%	-9.36%	-13.70%	0.36	2.86	67.60%	-5.60%	-7.97%
AZTA	AZENTA INC	$1.04B	-3.40%	-2.80%	-4.97%	-11.70%	0.21	2.92	44.60%	-9.70%	-15.11%
TNDM	TANDEM DIABETES CARE INC	$1.27B	-142.00%	-23.00%	-30.13%	-19.00%	4.68	2.55	53.80%	-20.20%	-18.96%
AHCO	ADAPTHEALTH CORP	$1.64B	-4.50%	-1.60%	2.38%	3.00%	1.84	1.02	18.80%	-2.20%	2.65%
CVS	CVS HEALTH CORP	$93.49B	2.30%	0.70%	3.21%	4.40%	2.37	0.84	13.80%	0.40%	1.32%
AIRS	AIRSCULPT TECHNOLOGIES INC	$223.63M	-13.80%	-6.00%	-7.25%	-8.90%	1.14	0.55	59.40%	-7.70%	-7.61%
LGND	LIGAND PHARMACEUTICALS INC	$3.98B	13.90%	10.20%	10.75%	17.20%	0.53	22.23	94.60%	46.40%	61.05%
ISRG	INTUITIVE SURGICAL INC	$160.54B	16.40%	14.40%	17.83%	23.80%	0.14	4.88	66.00%	28.40%	32.70%
ARGX	ARGENX SE	$46.19B	20.20%	17.40%	17.42%	34.00%	0.19	5.23	N/A	N/A	N/A
DOMH	DOMINARI HOLDINGS INC	$62.19M	-21.90%	-18.00%	N/A	-14.20%	0.63	N/A	100.00%	-18.20%	-12.28%
INSM	INSMED INC	$35.01B	-168.40%	-57.30%	-66.16%	-62.30%	2.06	3.83	79.70%	-210.50%	-195.90%
QTTB	Q32 BIO INC	$93.34M	1,630.20%	45.10%	59.13%	188.90%	0.47	4.85	100.00%	55.50%	55.49%
UTHR	UNITED THERAPEUTICS CORP	$24.75B	19.30%	17.30%	23.68%	31.70%	0.11	6.61	87.90%	41.90%	54.46%
ORMP	ORAMED PHARMACEUTICALS INC	$138.33M	36.70%	33.70%	35.58%	55.80%	0.16	6.98	0.60%	3,202.50%	3,767.90%
DOCS	DOXIMITY INC	$4.21B	22.90%	19.60%	27.43%	33.30%	0.18	6.63	89.70%	37.50%	43.32%
VIR	VIR BIOTECHNOLOGY INC	$1.26B	-49.30%	-38.70%	-48.11%	-53.00%	0.31	5.54	100.00%	-638.90%	-638.56%
KALV	KALVISTA PHARMACEUTICALS INC	$1.02B	N/A	N/A	N/A	N/A	-124.71	5.58	N/A	N/A	N/A
JYNT	JOINT CORP	$121.38M	14.40%	4.10%	10.47%	32.50%	3.05	1.59	79.60%	5.30%	5.37%
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$2.28B	-30.00%	-11.80%	-11.29%	-10.60%	1.32	3.34	74.20%	-21.50%	-17.23%
CYPH	CYPHERPUNK TECHNOLOGIES INC	$68.65M	10.60%	8.40%	6.37%	36.60%	0.06	35.56	N/A	N/A	N/A
BTMD	BIOTE CORP	$62.89M	-35.30%	24.20%	70.25%	34.50%	-2.70	1.22	71.50%	14.10%	22.89%
CERS	CERUS CORP	$357.44M	-26.40%	-7.30%	-5.72%	-3.40%	2.44	1.73	59.90%	-6.70%	-2.96%
ASND	ASCENDIS PHARMA A	$14.07B	N/A	-19.80%	-2.56%	-0.90%	-9.00	1.04	86.80%	-31.70%	-0.83%
NVS	NOVARTIS AG	$293.91B	32.70%	13.20%	20.93%	39.00%	1.40	1.12	75.80%	24.70%	30.90%
AKTS	AKTIS ONCOLOGY INC	$927.61M	N/A	-21.60%	-27.28%	-26.20%	-0.53	7.37	100.00%	-980.90%	-980.93%
SGHT	SIGHT SCIENCES INC	$190.10M	-55.70%	-31.80%	-31.91%	-66.10%	0.80	10.22	86.20%	-49.70%	-43.01%
DTIL	PRECISION BIOSCIENCES INC	$143.91M	-95.10%	-38.00%	-30.45%	-116.40%	0.67	13.32	100.00%	-133.40%	-129.30%
ABUS	ARBUTUS BIOPHARMA CORP	$875.74M	-42.40%	-32.50%	-37.70%	-47.50%	0.24	15.73	100.00%	-237.90%	-237.19%
ACAD	ACADIA PHARMACEUTICALS INC	$3.78B	41.90%	29.80%	10.79%	20.10%	0.27	3.83	91.70%	36.50%	12.96%
RLAY	RELAY THERAPEUTICS INC	$2.24B	-43.20%	-39.20%	-46.41%	-45.20%	0.10	22.61	100.00%	-1,800.60%	-1,800.58%
BIIB	BIOGEN INC	$26.03B	7.30%	4.50%	5.97%	12.30%	0.61	2.68	75.70%	13.10%	15.74%
QGEN	QIAGEN NV	$8.90B	11.90%	7.00%	9.07%	16.60%	0.66	3.90	62.20%	20.30%	25.05%
PDEX	PRO DEX INC	$165.65M	29.30%	18.00%	32.20%	26.90%	0.50	4.03	28.30%	15.70%	22.35%
FENC	FENNEC PHARMACEUTICALS INC	$221.33M	-220.90%	-18.50%	-12.58%	-23.60%	0.99	6.37	91.60%	-21.80%	-16.92%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$1.60B	19.80%	13.70%	22.53%	55.20%	0.46	3.60	77.20%	18.30%	26.45%
OPCH	OPTION CARE HEALTH INC	$4.30B	15.40%	6.10%	12.85%	16.80%	1.61	1.53	19.30%	3.70%	5.97%
IART	INTEGRA LIFESCIENCES HOLDINGS CORP	$742.31M	-44.50%	-13.80%	-15.17%	-16.10%	2.45	2.54	50.90%	-31.60%	-29.19%
BAX	BAXTER INTERNATIONAL INC	$8.58B	-13.80%	-4.60%	-1.90%	-2.10%	2.28	2.31	30.10%	-8.50%	-2.88%
TMDX	TRANSMEDICS GROUP INC	$3.45B	53.90%	20.30%	12.39%	12.70%	1.26	7.14	59.90%	31.40%	20.03%
ELV	ELEVANCE HEALTH INC	$66.37B	13.00%	4.70%	10.08%	13.10%	1.77	1.54	14.90%	2.80%	4.07%
CBLL	CERIBELL INC	$699.00M	-31.80%	-26.20%	-29.17%	-35.30%	0.26	9.73	87.90%	-60.00%	-57.85%
JNJ	JOHNSON & JOHNSON	$585.70B	33.80%	13.80%	23.13%	46.30%	1.44	1.03	67.90%	28.50%	35.62%
CSTL	CASTLE BIOSCIENCES INC	$738.52M	-5.30%	-4.40%	-5.77%	-8.70%	0.23	5.26	79.40%	-7.00%	-8.55%
NEO	NEOGENOMICS INC	$1.04B	-12.60%	-7.50%	-8.38%	-14.90%	0.63	4.26	43.20%	-14.90%	-14.64%
AMPH	AMPHASTAR PHARMACEUTICALS INC	$927.82M	12.80%	6.00%	10.14%	11.10%	1.07	4.02	49.50%	13.60%	20.71%
OMCL	OMNICELL INC	$1.55B	0.20%	0.10%	0.34%	0.90%	0.60	1.43	42.50%	0.20%	0.44%
RGEN	REPLIGEN CORP	$6.63B	2.40%	1.70%	2.98%	6.60%	0.40	8.37	52.30%	6.60%	11.36%
ALMS	ALUMIS INC	$2.97B	-72.60%	-54.90%	-74.39%	-96.50%	0.37	4.34	100.00%	-1,011.70%	-1,047.34%
KZIA	KAZIA THERAPEUTICS LTD	$416.03M	-217.80%	-51.20%	-52.23%	207.80%	0.53	2.87	100.00%	-1,200.90%	-1,285.72%
EBS	EMERGENT BIOSOLUTIONS INC	$426.07M	9.60%	3.70%	11.98%	11.50%	1.52	5.01	56.10%	7.10%	19.13%
AMRN	AMARIN CORP PLC	$306.65M	-8.40%	-5.80%	-7.57%	-10.50%	0.46	3.34	56.60%	-18.20%	-16.87%
TDOC	TELADOC HEALTH INC	$940.15M	-14.20%	-6.60%	-8.80%	-18.60%	1.06	2.77	69.50%	-7.90%	-8.53%
ATR	APTARGROUP INC	$8.11B	14.70%	8.00%	13.32%	20.50%	0.96	1.62	37.20%	10.40%	14.41%
SMTI	SANARA MEDTECH INC	$158.04M	-178.50%	-44.30%	-56.71%	-48.40%	11.29	1.80	92.70%	-36.40%	-29.87%
RCUS	ARCUS BIOSCIENCES INC	$2.88B	-65.80%	-32.50%	-38.00%	-47.30%	0.81	4.36	100.00%	-142.90%	-139.68%
ITGR	INTEGER HOLDINGS CORP	$2.99B	6.00%	3.10%	5.30%	6.70%	0.95	3.32	27.00%	5.50%	9.09%
PRVA	PRIVIA HEALTH GROUP INC	$2.62B	3.30%	1.80%	4.64%	-163.40%	0.79	1.60	9.90%	1.10%	1.75%
INMD	INMODE LTD	$873.72M	14.50%	12.90%	15.86%	25.30%	0.12	9.88	78.50%	25.30%	29.78%
TKNO	ALPHA TEKNOVA INC	$169.34M	-23.30%	-15.80%	-17.17%	-14.40%	0.51	4.58	33.20%	-42.60%	-40.70%
MIRM	MIRUM PHARMACEUTICALS INC	$5.68B	-8.50%	-3.10%	-1.10%	-1.70%	1.68	2.67	80.80%	-4.50%	-1.35%
ACHC	ACADIA HEALTHCARE COMPANY INC	$2.21B	-39.40%	-18.10%	-18.75%	-16.20%	1.74	1.55	34.10%	-33.30%	-28.31%
PTGX	PROTAGONIST THERAPEUTICS INC	$6.62B	-19.90%	-18.40%	-20.76%	-23.90%	0.09	12.71	100.00%	-282.80%	-281.01%
BRKR	BRUKER CORP	$5.60B	-1.10%	-0.40%	1.35%	1.50%	1.52	1.73	45.90%	-0.70%	1.95%
HSTM	HEALTHSTREAM INC	$600.34M	5.20%	3.60%	5.86%	41.00%	0.47	0.96	64.70%	6.00%	7.64%
ARWR	ARROWHEAD PHARMACEUTICALS INC	$8.55B	36.10%	13.60%	24.97%	17.70%	1.83	3.38	100.00%	18.50%	28.77%
ICLR	ICON PLC	$8.72B	6.30%	3.60%	6.18%	18.50%	0.77	1.06	28.10%	7.40%	10.13%
PHR	PHREESIA INC	$508.59M	0.70%	0.50%	-0.41%	-2.00%	0.97	1.53	67.90%	0.50%	-0.41%
PGEN	PRECIGEN INC	$1.39B	-14,393.40%	-308.30%	-208.78%	-195.80%	6.44	3.09	50.20%	-4,436.60%	-2,548.24%
SLN	SILENCE THERAPEUTICS PLC	$280.29M	N/A	-56.40%	-75.19%	-110.30%	-1.11	8.72	61.50%	-15,851.90%	-15,849.91%
ADAG	ADAGENE INC	$189.07M	-41.00%	-21.00%	-32.86%	113.30%	0.75	3.07	100.00%	-229.60%	-227.41%
WAY	WAYSTAR HOLDING CORP	$4.55B	3.30%	2.30%	4.48%	16.60%	0.49	1.41	68.30%	10.20%	22.68%
WEAV	WEAVE COMMUNICATIONS INC	$386.16M	-36.40%	-13.90%	-22.11%	-29.50%	1.52	1.24	72.10%	-11.70%	-11.41%
PLYX	POLARYX THERAPEUTICS INC	$338.03M	-193.70%	-176.70%	-196.82%	3,689.90%	0.13	8.55	N/A	N/A	N/A
CRON	CRONOS GROUP INC	$959.00M	-0.90%	-0.80%	-5.54%	-23.60%	0.05	19.59	42.80%	-6.40%	-43.39%
NRXS	NEURAXIS INC	$81.11M	-338.00%	-154.50%	-213.92%	690.70%	0.88	2.05	84.20%	-241.40%	-216.47%
CLOV	CLOVER HEALTH INVESTMENTS CORP	$902.43M	-25.70%	-15.10%	-25.75%	-42.00%	0.75	1.47	18.50%	-4.40%	-4.45%
VRCA	VERRICA PHARMACEUTICALS INC	$93.97M	N/A	-42.30%	-33.05%	-46.20%	0.91	2.59	90.30%	-50.30%	-28.51%
YCBD	CBDMD INC	$7.69M	-64.60%	-34.50%	-26.22%	-97.00%	0.31	2.94	60.60%	-19.50%	-12.37%
TSHA	TAYSHA GENE THERAPIES INC	$1.26B	-56.60%	-38.50%	-34.39%	-194.10%	0.39	12.23	100.00%	-1,115.30%	-1,114.62%
ARDX	ARDELYX INC	$1.46B	-40.60%	-13.20%	-9.81%	-7.80%	2.01	4.32	90.30%	-15.10%	-9.95%
ANL	ADLAI NORTYE LTD	$301.54M	-139.00%	-47.40%	-499.85%	552.50%	8.10	1.03	N/A	N/A	N/A
SEPN	SEPTERNA INC	$1.13B	-12.60%	-9.50%	-9.60%	-17.50%	0.56	4.73	100.00%	-106.40%	-106.35%
ABT	ABBOTT LABORATORIES	$178.76B	12.80%	7.80%	12.76%	19.60%	0.64	1.58	56.40%	14.70%	20.21%
VOR	VOR BIOPHARMA INC	$881.70M	N/A	-291.50%	-158.55%	-3,997.20%	-3.83	18.20	N/A	N/A	N/A
NTHI	NEONC TECHNOLOGIES HOLDINGS INC	$141.65M	N/A	-1,355.70%	346.41%	522.20%	-1.16	0.07	100.00%	-155,404.40%	-149,141.39%
BEAM	BEAM THERAPEUTICS INC	$2.51B	-7.30%	-5.70%	-5.78%	-7.50%	0.20	13.09	100.00%	-57.20%	-57.24%
RLYB	RALLYBIO CORP	$44.59M	-16.20%	-15.00%	-15.47%	-26.80%	0.07	14.51	100.00%	-1,046.40%	-1,046.39%
PBH	PRESTIGE CONSUMER HEALTHCARE INC	$2.48B	10.20%	5.40%	9.19%	21.60%	0.91	3.11	56.10%	16.90%	27.94%
ARDT	ARDENT HEALTH INC	$1.24B	11.00%	2.70%	5.83%	5.10%	2.80	1.97	17.80%	2.10%	3.91%
PHAT	PHATHOM PHARMACEUTICALS INC	$893.58M	N/A	-84.80%	-120.48%	-27.40%	-1.59	1.73	87.10%	-126.30%	-87.45%
KRYS	KRYSTAL BIOTECH INC	$7.63B	18.70%	17.10%	15.39%	26.00%	0.09	9.95	94.10%	52.60%	48.69%
CCCC	C4 THERAPEUTICS INC	$275.17M	-53.80%	-33.90%	-32.17%	-39.60%	0.40	7.81	100.00%	-292.10%	-291.74%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	606	-0.01%	+3.43%	-0.16%	-29.10%	28.69x	4.77x	-38.36%	-14.24%	-8.58%	+63.52%	Strong Buy
Diagnostics & Research	55	+0.31%	+1.69%	-3.45%	+10.47%	20.41x	3.69x	-2.71%	+6.61%	+12.95%	+25.93%	Strong Buy
Drug Manufacturers - General	20	-1.34%	+2.11%	-6.55%	+20.55%	32.72x	7.01x	+10.22%	+12.41%	+21.10%	+19.20%	Buy
Drug Manufacturers - Specialty & Generic	75	-1.19%	+0.83%	-6.28%	-27.18%	-196.18x	1.63x	+9.19%	+2.51%	+7.27%	+43.81%	Strong Buy
Healthcare Plans	10	+1.24%	+1.76%	-5.45%	-36.04%	22.78x	1.80x	+9.09%	+2.85%	+6.97%	+25.73%	Buy
Health Information Services	55	+0.55%	-0.27%	-8.49%	-80.30%	23.49x	2.80x	-7.72%	+2.33%	+4.64%	+61.04%	Buy
Medical Care Facilities	50	-0.22%	-1.38%	-10.26%	-42.38%	18.03x	5.29x	-68.62%	+7.35%	+19.11%	+25.02%	Buy
Medical Devices	137	-0.07%	-1.18%	-9.86%	-66.48%	23.94x	3.27x	+8.46%	+5.25%	+9.40%	+54.60%	Strong Buy
Medical Distribution	10	+1.45%	+2.26%	-10.46%	+25.96%	29.76x	317.88x	-99.39%	+3.30%	+23.34%	+14.03%	Strong Buy
Medical Instruments & Supplies	57	-0.61%	+0.07%	-7.92%	-10.20%	-490.95x	3.36x	+9.37%	+7.41%	+4.05%	+32.85%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Apr 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: B, Financials: A, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 44, which is 17 points higher than the healthcare sector average of 27. It passed 14 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock lose -5.68% over the past year, overperforming other healthcare stocks by 30 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 67.22% from Bioventus's current stock price of $8.97.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

Amneal Pharmaceuticals (NASDAQ:AMRX) is the #2 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: A, Momentum: B, Sentiment: B, Safety: C, Financials: C, and AI: C.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 35, which is 8 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Amneal Pharmaceuticals has seen its stock return 52.75% over the past year, overperforming other healthcare stocks by 88 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $15.00, an upside of 20.19% from Amneal Pharmaceuticals's current stock price of $12.48.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

Aveanna Healthcare Holdings (NASDAQ:AVAH) is the #3 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aveanna Healthcare Holdings (NASDAQ:AVAH) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Aveanna Healthcare Holdings (NASDAQ:AVAH) has a Due Diligence Score of 32, which is 5 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Aveanna Healthcare Holdings has seen its stock return 13.52% over the past year, overperforming other healthcare stocks by 49 percentage points.

Aveanna Healthcare Holdings has an average 1 year price target of $10.00, an upside of 56.74% from Aveanna Healthcare Holdings's current stock price of $6.38.

Aveanna Healthcare Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Aveanna Healthcare Holdings, 33.33% have issued a Strong Buy rating, 16.67% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

Novabay Pharmaceuticals (NYSEMKT:NBY) has an annual dividend yield of 205.13%, which is 200 percentage points higher than the healthcare sector average of 4.92%.

Novabay Pharmaceuticals's dividend payout ratio of -105.3% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 24.18%, which is 19 percentage points higher than the healthcare sector average of 4.92%.

Dominari Holdings's dividend payout ratio of -42.4% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 11.23%, which is 6 percentage points higher than the healthcare sector average of 4.92%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 162.3% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.05% in the last day, and up 1.62% over the last week. Lipocine was the among the top losers in the healthcare sector, dropping -77.84% yesterday.

Lipocine shares are trading lower after the company's LPCN 1154 missed its Phase 3 primary endpoint in postpartum depression.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 86, which is 70 points higher than the healthcare sector average of 16. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has dropped -29.31% in the past year. It has overperformed other stocks in the healthcare sector by 6 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 145.83% in the past year. It has overperformed other stocks in the healthcare sector by 181 percentage points.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -14.72% in the past year. It has overperformed other stocks in the healthcare sector by 21 percentage points.

Are healthcare stocks a good buy now?

58.29% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 44.05% over the next year.

5.73% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.7% of healthcare stocks are rated B (Buy), 50.93% are rated C (Hold), 23.91% are rated D (Sell), and 6.72% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is -8.01x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.